Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127978231 | 12797823 | 1 | I | 20160606 | 20160915 | 20160930 | 20160930 | EXP | GB-MHRA-ADR 23642231 | GB-ALVOGEN-2016-ALVOGEN-028771 | ALVOGEN | 0.00 | F | Y | 0.00000 | 20160930 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127978231 | 12797823 | 1 | PS | LISINOPRIL. | LISINOPRIL | 1 | Oral | Y | 19777 | 20 | MG | TABLET | QD | ||||||
| 127978231 | 12797823 | 2 | SS | DIGOXIN. | DIGOXIN | 1 | Oral | Y | 0 | 250 | UG | ||||||||
| 127978231 | 12797823 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
| 127978231 | 12797823 | 4 | C | FOSTAIR | BECLOMETHASONEFORMOTEROL | 1 | 0 | ||||||||||||
| 127978231 | 12797823 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 127978231 | 12797823 | 6 | C | IBANDRONIC ACID | IBANDRONIC ACID | 1 | 0 | ||||||||||||
| 127978231 | 12797823 | 7 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 0 | ||||||||||||
| 127978231 | 12797823 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 127978231 | 12797823 | 9 | C | TIOTROPIUM BROMIDE | TIOTROPIUM BROMIDE | 1 | 0 | ||||||||||||
| 127978231 | 12797823 | 10 | C | WARFARIN | WARFARIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127978231 | 12797823 | 1 | Hypertension |
| 127978231 | 12797823 | 2 | Atrial fibrillation |
| 127978231 | 12797823 | 3 | Product used for unknown indication |
| 127978231 | 12797823 | 4 | Product used for unknown indication |
| 127978231 | 12797823 | 5 | Product used for unknown indication |
| 127978231 | 12797823 | 6 | Product used for unknown indication |
| 127978231 | 12797823 | 7 | Product used for unknown indication |
| 127978231 | 12797823 | 8 | Product used for unknown indication |
| 127978231 | 12797823 | 9 | Product used for unknown indication |
| 127978231 | 12797823 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127978231 | 12797823 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127978231 | 12797823 | Acute kidney injury | |
| 127978231 | 12797823 | Decreased appetite | |
| 127978231 | 12797823 | Fluid intake reduced | |
| 127978231 | 12797823 | Hyperkalaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127978231 | 12797823 | 1 | 20160607 | 0 | ||
| 127978231 | 12797823 | 2 | 20160607 | 0 |